Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109897872B reveals enzymatic route for HIV intermediate. High conversion and purity ensure reliable pharmaceutical intermediates supplier capability for global procurement.
Patent CN113025544A reveals efficient whole-cell catalysis for L-phenyllactic acid. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104263768A reveals Candida biocatalysis for chiral esters. Offers high yield and ee. Reliable supply chain and cost reduction for pharmaceutical manufacturing.
Patent CN114835666A reveals a continuous flow method for Pro-Xylane production, offering higher purity, safety, and cost reduction in fine chemical manufacturing.
Patent CN109897872B details enzymatic reduction for HIV inhibitor intermediates. High purity and conversion enable cost reduction and reliable supply chain stability for global manufacturers.
Patent CN86105165A details novel cyclohexanealkanoic acids for asthma treatment. Discover cost-effective synthesis routes and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN113024624A details a novel 8-step synthesis of deoxycholic acid from cholic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN118272331B reveals high-efficiency ene reductase mutant for (R)-citronellal. Delivers superior optical purity and scalable biocatalysis for global supply chains.
Patent CN118955276A details a novel oxidation-hydrolysis route for 2-bromo-5-hydroxybenzoic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN101333554B reveals enzymatic resolution for D-lactic acid. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN100351219C details a novel Grignard route for CoQ10, offering significant yield improvements and cost reduction potential for global pharmaceutical manufacturers.
Patent CN112745273A reveals a high-yield synthesis for Nifuratel impurity standards, offering reliable supply chain solutions and cost-effective manufacturing for pharmaceutical quality control.
Novel reductive amination route for PARP inhibitor intermediate TSL-1502M ensures high purity and scalable manufacturing for global supply chains.
Patent CN107089979B reveals improved synthesis for Palonosetron Hcl. Enhanced yield and simplified chiral control offer supply chain stability.
Novel deuterated Palbociclib derivative patent CN106967064A offers improved metabolic stability and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103664773A reveals a water-based purification method for Milrinone, reducing costs and improving purity for cardiovascular API manufacturing.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel patent CN105367505A offers mild conditions for high-purity 3 6-dimethyl-2 5-dioxopiperazine ensuring cost reduction and supply reliability for pharma intermediates manufacturing processes globally
Novel patent CN105153124B offers milder conditions and higher purity for Candesartan Cilexetil manufacturing, ensuring supply chain reliability.